Synthetic biosensors are engineered biological systems that detect specific chemical or physical inputs—such as pathogens, toxins, or biomarkers—and convert them into measurable signals. They combine bespoke proteins, genetic circuits, and CRISPR-based tools to enable ultra-sensitive, real-time tracking in medicine, environmental monitoring, and biotechnology.
These technologies typically fall into two primary formats, both of which are increasingly enhanced by artificial intelligence for targeted design:
- Whole-Cell Biosensors: Living engineered organisms (such as E. coli or yeast) that respond to environmental stimuli or metabolic states, frequently used for detecting heavy metals or disease states.
- Cell-Free Biosensors: These systems bypass cell viability by using purified cellular machinery or freeze-dried extracts (like in vitro transcription-translation modules). They offer rapid, field-ready, and biosafe diagnostic testing without the regulatory complexities of releasing living modified organisms.
For in-depth analysis on how this field is being leveraged for point-of-care diagnostics, explore Synthetic Biology-Enabled Biosensing Platforms published in the MDPI journal, or review current healthcare applications via the ScienceDirect Special Issue.
Leave a Reply